Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  INDONESIA STOCK EXCHANGE  >  Kalbe Farma Tbk PT    KLBF   ID1000125107

KALBE FARMA TBK PT

(KLBF)
  Report
 SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (IDR)
Sales 2019 22 845 B
EBIT 2019 3 525 B
Net income 2019 2 665 B
Finance 2019 2 807 B
Yield 2019 1,86%
Sales 2020 24 511 B
EBIT 2020 3 757 B
Net income 2020 2 832 B
Finance 2020 2 682 B
Yield 2020 1,97%
P/E ratio 2019 25,0x
P/E ratio 2020 23,5x
EV / Sales2019 2 914x
EV / Sales2020 2 715x
Capitalization 66 563 B
More Financials
Company
PT Kalbe Farma Tbk is an Indonesia-based company primarily engaged in manufacturing health and nutritional as well as pharmaceutical products. Its business is classified into four segments: prescription drugs, health products, nutritional products as well as distribution and logistics. Its... 
Sector
Pharmaceuticals
Calendar
03/27Earnings Release
More about the company
Surperformance© ratings of Kalbe Farma Tbk PT
Trading Rating : Investor Rating :
More Ratings
Latest news on KALBE FARMA TBK PT
02/05KALBE FARMA TBK PT : Change of Corporate Secretary of PT Kalbe Farma Tbk
PU
2019KALBE FARMA TBK PT : Disclosure of Information - Increased in Issued and Paid in..
PU
2019KALBE FARMA TBK PT : Disclosure of Information - Increased in Issued and Paid in..
PU
2019KALBE FARMA TBK PT : Growth Improvement in Sales and Net Income
PU
2019Indonesia hikes state health insurer's premiums to plug deficit
RE
2019KALBE FARMA TBK PT : Disclosure of Information - Establishment of a Subsidiary, ..
PU
2019KALBE FARMA TBK PT : Will Participate In CPhI In Frankfurt
PU
2019KALBE FARMA TBK PT : Commemorates World Hepatitis Day
PU
2019KALBE FARMA TBK PT : Genexine Biologics Enters Into an Exclusive Licensing of Im..
PU
2019KALBE FARMA TBK PT : Maintain Better Company Performance
PU
2019KALBE FARMA TBK PT : Ex-dividend day for final dividend
FA
2019KALBE FARMA TBK PT : Additional Information for the Annual General Meeting of Sh..
PU
2019KALBE FARMA TBK PT : Expecting a Better Growth
PU
2019KALBE FARMA TBK PT : Announcement to the Shareholders regarding the Annual Gener..
PU
2019KALBE FARMA TBK PT : Growing in the Challenging Environment
PU
More news
News in other languages on KALBE FARMA TBK PT
2019KALBE FARMA TBK PT : Ex-dividend day for final dividend
2018KALBE FARMA TBK PT : Ex-dividend day for final dividend
2017KALBE FARMA TBK PT : Ex-dividend day for final dividend
2016KALBE FARMA TBK PT : Ex-dividend day for final dividend
2015KALBE FARMA TBK PT : Ex-dividend day for final dividend
More news
Analyst Recommendations on KALBE FARMA TBK PT
More recommendations
Sector news : Pharmaceuticals - NEC
07:53pTEVA : Registration Trials in Tourette Syndrome Didn't Meet Primary Endpoint
DJ
01:46pEXCLUSIVE : Canadian regulator considers changes to new drug pricing plan
RE
01:26pFresenius forecasts 2020 profit growth driven by drug, dialysis units
RE
11:38aSHANGHAI FOSUN PHARMACEUTICAL : banks issue 1.31 billion yuan in cheap loans to ..
RE
10:35aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 1 740,83  IDR
Last Close Price 1 420,00  IDR
Spread / Highest target 40,8%
Spread / Average Target 22,6%
Spread / Lowest Target -15,5%
EPS Revisions
Managers
NameTitle
Vidjongtius President Director
Bernadette Ruth Setiady President Commissioner
Dino Bramanto Head-Corporate Information Technology & System
Santoso Oen Commissioner
Ferdinand Aryanto Commissioner
Sector and Competitors
1st jan.Capitalization (M$)
KALBE FARMA TBK PT4 906
JOHNSON & JOHNSON2.24%392 415
ROCHE HOLDING AG10.05%303 192
NOVARTIS3.81%220 641
MERCK AND COMPANY-9.84%208 771
PFIZER-7.30%200 501